Recombinant multi-species SNRNP200 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNRNP200 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Pre-mRNA splicing is catalyzed by the spliceosome, a complex of specialized RNA and protein subunits that removes introns from a transcribed pre-mRNA segment. The spliceosome consists of small nuclear RNA proteins (snRNPs) U1, U2, U4, U5 and U6, together with approximately 80 conserved proteins. U5 snRNP contains nine specific proteins. This gene encodes one of the U5 snRNP-specific proteins. This protein belongs to the DEXH-box family of putative RNA helicases. It is a core component of U4/U6-U5 snRNPs and appears to catalyze an ATP-dependent unwinding of U4/U6 RNA duplices. Mutations in this gene cause autosomal-dominant retinitis pigmentosa. Alternatively spliced transcript variants encoding different isoforms have been found, but the full-length nature of these variants has not been determined. [provided by RefSeq, Mar 2010]
The Alternative Names of target: A330064G03Rik,ASCC3L1,Activating signal cointegrator 1 complex subunit 3-like 1,Ascc3l1,BRR2,BRR2 homolog,HELIC2,RP33,SNRNP200,Snrnp200,U5 small nuclear ribonucleoprotein 200 kDa helicase,U5 snRNP-specific 200 kDa protein (U5-200KD),U5-200-KD,U5-200KD

Target products collectionGo to SNRNP200 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6682-Ag-1/ GM-Tg-hg-IP6682-Ag-2 Human SNRNP200 protein Human
GM-Tg-rg-IP6682-Ag-1/ GM-Tg-rg-IP6682-Ag-2 Rat SNRNP200 protein Rat
GM-Tg-mg-IP6682-Ag-1/ GM-Tg-mg-IP6682-Ag-2 Mouse SNRNP200 protein Mouse
GM-Tg-cynog-IP6682-Ag-1/ GM-Tg-cynog-IP6682-Ag-2 Cynomolgus/Rhesus macaque SNRNP200 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6682-Ag-1/ GM-Tg-felg-IP6682-Ag-2 Feline SNRNP200 protein Feline
GM-Tg-cang-IP6682-Ag-1/ GM-Tg-cang-IP6682-Ag-2 Canine SNRNP200 protein Canine
GM-Tg-bovg-IP6682-Ag-1/ GM-Tg-bovg-IP6682-Ag-2 Bovine SNRNP200 protein Bovine
GM-Tg-equg-IP6682-Ag-1/ GM-Tg-equg-IP6682-Ag-2 Equine SNRNP200 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6682-Ag-1/ GM-Tg-hg-IP6682-Ag-2; GM-Tg-rg-IP6682-Ag-1/ GM-Tg-rg-IP6682-Ag-2;
GM-Tg-mg-IP6682-Ag-1/ GM-Tg-mg-IP6682-Ag-2; GM-Tg-cynog-IP6682-Ag-1/ GM-Tg-cynog-IP6682-Ag-2;
GM-Tg-felg-IP6682-Ag-1/ GM-Tg-felg-IP6682-Ag-2; GM-Tg-cang-IP6682-Ag-1/ GM-Tg-cang-IP6682-Ag-2;
GM-Tg-bovg-IP6682-Ag-1/ GM-Tg-bovg-IP6682-Ag-2; GM-Tg-equg-IP6682-Ag-1/ GM-Tg-equg-IP6682-Ag-2
Products Name SNRNP200 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SNRNP200
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNRNP200 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.